▶ 調査レポート

髄膜炎菌ワクチンの世界市場レポート2020

• 英文タイトル:Global Meningococcal Vaccine Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。髄膜炎菌ワクチンの世界市場レポート2020 / Global Meningococcal Vaccine Sales Market Report 2020 / 20QY06-06844資料のイメージです。• レポートコード:20QY06-06844
• 出版社/出版日:QYResearch / 2020年6月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、142ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、髄膜炎菌ワクチンのグローバル市場について種類別(四価、二価、その他)、用途別(肺炎、髄膜炎、菌血症、その他(関節炎、結膜炎、尿道炎))、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・髄膜炎菌ワクチン市場の概要
・世界の主要地域別髄膜炎菌ワクチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の髄膜炎菌ワクチン市場規模2015-2026:種類別(四価、二価、その他)
・世界の髄膜炎菌ワクチン市場規模2015-2026:用途別(肺炎、髄膜炎、菌血症、その他(関節炎、結膜炎、尿道炎))
・髄膜炎菌ワクチンの北米市場規模2015-2020
・髄膜炎菌ワクチンのヨーロッパ市場規模2015-2020
・髄膜炎菌ワクチンの中国市場規模2015-2020
・髄膜炎菌ワクチンの日本市場規模2015-2020
・髄膜炎菌ワクチンの東南アジア市場規模2015-2020
・髄膜炎菌ワクチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Novartis、GSK、Merck、CSL、Baxter、JN International Medical Corporation、Serum Institute of India、Bio-Med、China National Biotec Group、Hualan Bio、Walvax、Zhifei)
・髄膜炎菌ワクチンの製造コスト分析
・販売チャネル、流通業者、顧客
・髄膜炎菌ワクチンの市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Meningococcal Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Meningococcal Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Meningococcal Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Meningococcal Vaccine industry.
Based on our recent survey, we have several different scenarios about the Meningococcal Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 239 million in 2019. The market size of Meningococcal Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Meningococcal Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Meningococcal Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Meningococcal Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Meningococcal Vaccine market. The report also includes nautical information, where it shows Meningococcal Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Meningococcal Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Meningococcal Vaccine market.
Geographical Analysis:
Based on region, the global Meningococcal Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Meningococcal Vaccine market are
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Segment by Type
Quadrivalent
Bivalent
Others
Segment by Application
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Meningococcal Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Meningococcal Vaccine market.
• The market share of the global Meningococcal Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Meningococcal Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Meningococcal Vaccine market.

レポート目次

1 Meningococcal Vaccine Market Overview
1.1 Meningococcal Vaccine Product Scope
1.2 Meningococcal Vaccine Segment by Type
1.2.1 Global Meningococcal Vaccine Sales by Type (2020-2026)
1.2.2 Quadrivalent
1.2.3 Bivalent
1.2.4 Others
1.3 Meningococcal Vaccine Segment by Application
1.3.1 Global Meningococcal Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Meningococcal Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Meningococcal Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Meningococcal Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Meningococcal Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Meningococcal Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Meningococcal Vaccine Industry
1.5.1.1 Meningococcal Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Meningococcal Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Meningococcal Vaccine Players to Combat Covid-19 Impact

2 Meningococcal Vaccine Estimate and Forecast by Region
2.1 Global Meningococcal Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Meningococcal Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Meningococcal Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Meningococcal Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Meningococcal Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Meningococcal Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Meningococcal Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Meningococcal Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Meningococcal Vaccine Estimates and Projections (2015-2026)
2.4.3 China Meningococcal Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Meningococcal Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Meningococcal Vaccine Estimates and Projections (2015-2026)
2.4.6 India Meningococcal Vaccine Estimates and Projections (2015-2026)
3 Global Meningococcal Vaccine Competition Landscape by Players
3.1 Global Top Meningococcal Vaccine Players by Sales (2015-2020)
3.2 Global Top Meningococcal Vaccine Players by Revenue (2015-2020)
3.3 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccine as of 2019)
3.4 Global Meningococcal Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Meningococcal Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Meningococcal Vaccine Players (Opinion Leaders)
4 Global Meningococcal Vaccine Market Size by Type
4.1 Global Meningococcal Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Meningococcal Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Meningococcal Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Meningococcal Vaccine Price by Type (2014-2020)
4.2 Global Meningococcal Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Meningococcal Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Meningococcal Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Meningococcal Vaccine Price Forecast by Type (2021-2026)
5 Global Meningococcal Vaccine Market Size by Application
5.1 Global Meningococcal Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Meningococcal Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Meningococcal Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Meningococcal Vaccine Price by Application (2015-2020)
5.2 Global Meningococcal Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Meningococcal Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Meningococcal Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Meningococcal Vaccine Price Forecast by Application (2021-2026)

3 North America Meningococcal Vaccine Market Facts & Figures
3.2 North America Meningococcal Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Meningococcal Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Meningococcal Vaccine Sales Market Share by Application (2015-2020)

4 Europe Meningococcal Vaccine Market Facts & Figures
4.2 Europe Meningococcal Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Meningococcal Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Meningococcal Vaccine Sales Market Share by Application (2015-2020)

5 China Meningococcal Vaccine Market Facts & Figures
5.2 China Meningococcal Vaccine Sales Market Share by Company (2015-2020)
5.3 China Meningococcal Vaccine Sales Market Share by Type (2015-2020)
5.4 China Meningococcal Vaccine Sales Market Share by Application (2015-2020)

6 Japan Meningococcal Vaccine Market Facts & Figures
6.2 Japan Meningococcal Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Meningococcal Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Meningococcal Vaccine Sales Market Share by Application (2015-2020)

7 Southeast Asia Meningococcal Vaccine Market Facts & Figures
7.2 Southeast Asia Meningococcal Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Meningococcal Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Meningococcal Vaccine Sales Market Share by Application (2015-2020)

8 India Meningococcal Vaccine Market Facts & Figures
8.2 India Meningococcal Vaccine Sales Market Share by Company (2015-2020)
8.3 India Meningococcal Vaccine Sales Market Share by Type (2015-2020)
8.4 India Meningococcal Vaccine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Meningococcal Vaccine Business
12.1 Novartis
12.1.1 Novartis Meningococcal Vaccine Corporation Information
12.1.2 Novartis Meningococcal Vaccine Business Overview and Total Revenue
12.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Meningococcal Vaccine Products Offered
12.1.5 Novartis Recent Development
12.2 GSK
12.2.1 GSK Meningococcal Vaccine Corporation Information
12.2.2 GSK Meningococcal Vaccine Business Overview and Total Revenue
12.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Meningococcal Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Merck
12.3.1 Merck Meningococcal Vaccine Corporation Information
12.3.2 Merck Meningococcal Vaccine Business Overview and Total Revenue
12.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Meningococcal Vaccine Products Offered
12.3.5 Merck Recent Development
12.4 CSL
12.4.1 CSL Meningococcal Vaccine Corporation Information
12.4.2 CSL Meningococcal Vaccine Business Overview and Total Revenue
12.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 CSL Meningococcal Vaccine Products Offered
12.4.5 CSL Recent Development
12.5 Baxter
12.5.1 Baxter Meningococcal Vaccine Corporation Information
12.5.2 Baxter Meningococcal Vaccine Business Overview and Total Revenue
12.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Baxter Meningococcal Vaccine Products Offered
12.5.5 Baxter Recent Development
12.6 JN International Medical Corporation
12.6.1 JN International Medical Corporation Meningococcal Vaccine Corporation Information
12.6.2 JN International Medical Corporation Meningococcal Vaccine Business Overview and Total Revenue
12.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 JN International Medical Corporation Meningococcal Vaccine Products Offered
12.6.5 JN International Medical Corporation Recent Development
12.7 Serum Institute of India
12.7.1 Serum Institute of India Meningococcal Vaccine Corporation Information
12.7.2 Serum Institute of India Meningococcal Vaccine Business Overview and Total Revenue
12.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Serum Institute of India Meningococcal Vaccine Products Offered
12.7.5 Serum Institute of India Recent Development
12.8 Bio-Med
12.8.1 Bio-Med Meningococcal Vaccine Corporation Information
12.8.2 Bio-Med Meningococcal Vaccine Business Overview and Total Revenue
12.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bio-Med Meningococcal Vaccine Products Offered
12.8.5 Bio-Med Recent Development
12.9 China National Biotec Group
12.9.1 China National Biotec Group Meningococcal Vaccine Corporation Information
12.9.2 China National Biotec Group Meningococcal Vaccine Business Overview and Total Revenue
12.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 China National Biotec Group Meningococcal Vaccine Products Offered
12.9.5 China National Biotec Group Recent Development
12.10 Hualan Bio
12.10.1 Hualan Bio Meningococcal Vaccine Corporation Information
12.10.2 Hualan Bio Meningococcal Vaccine Business Overview and Total Revenue
12.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Hualan Bio Meningococcal Vaccine Products Offered
12.10.5 Hualan Bio Recent Development
12.11 Walvax
12.11.1 Walvax Meningococcal Vaccine Corporation Information
12.11.2 Walvax Meningococcal Vaccine Business Overview and Total Revenue
12.11.3 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Walvax Meningococcal Vaccine Products Offered
12.11.5 Walvax Recent Development
12.12 Zhifei
12.12.1 Zhifei Meningococcal Vaccine Corporation Information
12.12.2 Zhifei Meningococcal Vaccine Business Overview and Total Revenue
12.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Zhifei Meningococcal Vaccine Products Offered
12.12.5 Zhifei Recent Development

13 Meningococcal Vaccine Manufacturing Cost Analysis
13.1 Meningococcal Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Meningococcal Vaccine
13.4 Meningococcal Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Meningococcal Vaccine Distributors List
14.3 Meningococcal Vaccine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Meningococcal Vaccine Sales (K Dose) Growth Rate by Type (2020-2026)
Table 2. Global Meningococcal Vaccine Sales (K Dose) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Meningococcal Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Meningococcal Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Meningococcal Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Meningococcal Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Meningococcal Vaccine Sales (K Dose) by Region (2015-2020)
Table 10. Global Meningococcal Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Meningococcal Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Meningococcal Vaccine Sales (K Dose) Forecast by Region (2021-2026)
Table 14. Global Meningococcal Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Meningococcal Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Meningococcal Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Meningococcal Vaccine (K Dose) of Key Companies (2015-2020)
Table 18. Global Meningococcal Vaccine Sales Share by Company (2015-2020)
Table 19. Global Meningococcal Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Meningococcal Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccine as of 2019)
Table 22. Global Meningococcal Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Meningococcal Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Meningococcal Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Meningococcal Vaccine Players
Table 27. Global Meningococcal Vaccine Sales (K Dose) by Type (2015-2020)
Table 28. Global Meningococcal Vaccine Sales Share by Type (2015-2020)
Table 29. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Meningococcal Vaccine Price (K Dose) by Type (2015-2020)
Table 31. Global Meningococcal Vaccine Sales Share by Type (2021-2026)
Table 32. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Meningococcal Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Meningococcal Vaccine Price (K Dose) by Type (2021-2026)
Table 35. Global Meningococcal Vaccine Sales (K Dose) by Application (2015-2020)
Table 36. Global Meningococcal Vaccine Sales Share by Application (2015-2020)
Table 37. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Meningococcal Vaccine Price (K Dose) by Application (2015-2020)
Table 39. Global Meningococcal Vaccine Sales (K Dose) by Application (2021-2026)
Table 40. Global Meningococcal Vaccine Sales Share by Application (2021-2026)
Table 41. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Meningococcal Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Meningococcal Vaccine Price (K Dose) by Application (2021-2026)
Table 44. United States Meningococcal Vaccine Sales (K Dose) by Company (2015-2020)
Table 45. United States Meningococcal Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Meningococcal Vaccine Sales (K Dose) by Type (2015-2020)
Table 47. United States Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Meningococcal Vaccine Sales (K Dose) by Application (2015-2020)
Table 49. United States Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Meningococcal Vaccine Sales (K Dose) by Company (2015-2020)
Table 51. Europe Meningococcal Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Meningococcal Vaccine Sales (K Dose) by Type (2015-2020)
Table 53. Europe Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Meningococcal Vaccine Sales (K Dose) by Application (2015-2020)
Table 55. Europe Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Meningococcal Vaccine Sales (K Dose) by Company (2015-2020)
Table 57. China Meningococcal Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Meningococcal Vaccine Sales (K Dose) by Type (2015-2020)
Table 59. China Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Meningococcal Vaccine Sales (K Dose) by Application (2015-2020)
Table 61. China Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Meningococcal Vaccine Sales (K Dose) by Company (2015-2020)
Table 63. Japan Meningococcal Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Meningococcal Vaccine Sales (K Dose) by Type (2015-2020)
Table 65. Japan Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Meningococcal Vaccine Sales (K Dose) by Application (2015-2020)
Table 67. Japan Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Meningococcal Vaccine Sales (K Dose) by Company (2015-2020)
Table 69. Southeast Asia Meningococcal Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Meningococcal Vaccine Sales (K Dose) by Type (2015-2020)
Table 71. Southeast Asia Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Meningococcal Vaccine Sales (K Dose) by Type (2015-2020)
Table 73. Southeast Asia Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Meningococcal Vaccine Sales (K Dose) by Company (2015-2020)
Table 75. India Meningococcal Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Meningococcal Vaccine Sales (K Dose) by Type (2015-2020)
Table 77. India Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Meningococcal Vaccine Sales (K Dose) by Application (2015-2020)
Table 79. India Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Novartis Meningococcal Vaccine Product
Table 84. Novartis Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. GSK Meningococcal Vaccine Product
Table 89. GSK Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Merck Meningococcal Vaccine Product
Table 94. Merck Recent Development
Table 95. CSL Corporation Information
Table 96. CSL Description and Business Overview
Table 97. CSL Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. CSL Meningococcal Vaccine Product
Table 99. CSL Recent Development
Table 100. Baxter Corporation Information
Table 101. Baxter Description and Business Overview
Table 102. Baxter Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Baxter Meningococcal Vaccine Product
Table 104. Baxter Recent Development
Table 105. JN International Medical Corporation Corporation Information
Table 106. JN International Medical Corporation Description and Business Overview
Table 107. JN International Medical Corporation Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. JN International Medical Corporation Meningococcal Vaccine Product
Table 109. JN International Medical Corporation Recent Development
Table 110. Serum Institute of India Corporation Information
Table 111. Serum Institute of India Description and Business Overview
Table 112. Serum Institute of India Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Serum Institute of India Meningococcal Vaccine Product
Table 114. Serum Institute of India Recent Development
Table 115. Bio-Med Corporation Information
Table 116. Bio-Med Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Bio-Med Description and Business Overview
Table 118. Bio-Med Meningococcal Vaccine Product
Table 119. Bio-Med Recent Development
Table 120. China National Biotec Group Corporation Information
Table 121. China National Biotec Group Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. China National Biotec Group Description and Business Overview
Table 123. China National Biotec Group Meningococcal Vaccine Product
Table 124. China National Biotec Group Recent Development
Table 125. Hualan Bio Corporation Information
Table 126. Hualan Bio Description and Business Overview
Table 127. Hualan Bio Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Hualan Bio Meningococcal Vaccine Product
Table 129. Hualan Bio Recent Development
Table 130. Walvax Corporation Information
Table 131. Walvax Description and Business Overview
Table 132. Walvax Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Walvax Meningococcal Vaccine Product
Table 134. Walvax Recent Development
Table . Zhifei Corporation Information
Table . Zhifei Description and Business Overview
Table . Zhifei Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Zhifei Meningococcal Vaccine Product
Table . Zhifei Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Meningococcal Vaccine Distributors List
Table 143. Meningococcal Vaccine Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Vaccine Product Picture
Figure 2. Global Meningococcal Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Meningococcal Vaccine Market Share by Application in 2020 & 2026
Figure 6. Pneumonia Examples
Figure 7. Meningitis Examples
Figure 8. Bacteremia Examples
Figure 9. Others (Arthritis, Conjunctivitis, Urethritis) Examples
Figure 10. Global Meningococcal Vaccine Sales (K Dose) Growth Rate (2015-2026)
Figure 11. Global Meningococcal Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Meningococcal Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 13. Global Meningococcal Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Meningococcal Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Meningococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Meningococcal Vaccine Sales (K Dose) Growth Rate (2015-2026)
Figure 17. Europe Meningococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Meningococcal Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Meningococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Meningococcal Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Meningococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Meningococcal Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Meningococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Meningococcal Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Meningococcal Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Meningococcal Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Meningococcal Vaccine Players Market Share by Revenue in Meningococcal Vaccine 2015 & 2019
Figure 28. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Meningococcal Vaccine Revenue Share by Type (2015-2020)
Figure 30. Global Meningococcal Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Meningococcal Vaccine Revenue Share by Application (2015-2020)
Figure 32. Global Meningococcal Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Meningococcal Vaccine Sales Market Share by Type in 2019
Figure 34. United States Meningococcal Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Meningococcal Vaccine Sales Market Share by Company in 2019
Figure 36. Europe Meningococcal Vaccine Sales Market Share by Type in 2019
Figure 37. Europe Meningococcal Vaccine Sales Market Share by Application in 2019
Figure 38. China Meningococcal Vaccine Sales Market Share by Company in 2019
Figure 39. China Meningococcal Vaccine Sales Market Share by Type in 2019
Figure 40. China Meningococcal Vaccine Sales Market Share by Application in 2019
Figure 41. Japan Meningococcal Vaccine Sales Market Share by Company in 2019
Figure 42. Japan Meningococcal Vaccine Sales Market Share by Type in 2019
Figure 43. Japan Meningococcal Vaccine Sales Market Share by Application in 2019
Figure 44. Southeast Asia Meningococcal Vaccine Sales Market Share by Company in 2019
Figure 45. Southeast Asia Meningococcal Vaccine Sales Market Share by Type in 2019
Figure 46. Southeast Asia Meningococcal Vaccine Sales Market Share by Application in 2019
Figure 47. India Meningococcal Vaccine Sales Market Share by Company in 2019
Figure 48. India Meningococcal Vaccine Sales Market Share by Type in 2019
Figure 49. India Meningococcal Vaccine Sales Market Share by Application in 2019
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. JN International Medical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bio-Med Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. China National Biotec Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Walvax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Zhifei Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Meningococcal Vaccine
Figure 64. Manufacturing Process Analysis of Meningococcal Vaccine
Figure 65. Meningococcal Vaccine Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed